المؤلفون: Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J.P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., El-Hussuna, A., Ellul, P., Frei-Lanter, C., Furfaro, F., Gingert, C., Gionchetti, P., Gomollon, F., Gonzalez-Lorenzo, M., Gordon, H., Hlavaty, T., Juillerat, P., Katsanos, K., Kopylov, U., Krustins, E., Lytras, T., Maaser, C., Magro, F., Marshall, J.K., Myrelid, P., Pellino, G., Rosa, I., Sabino, J., Savarino, E., Spinelli, A., Stassen, L., Uzzan, M., Vavricka, S., Verstockt, B., Warusavitarne, J., Zmora, O., Fiorino, G.

المصدر: Torres , J , Bonovas , S , Doherty , G , Kucharzik , T , Gisbert , J P , Raine , T , Adamina , M , Armuzzi , A , Bachmann , O , Bager , P , Biancone , L , Bokemeyer , B , Bossuyt , P , Burisch , J , Collins , P , El-Hussuna , A , Ellul , P , Frei-Lanter , C , Furfaro , F , Gingert , C , Gionchetti , P , Gomollon , F , Gonzalez-Lorenzo , M , Gordon , H , Hlavaty , ....

مصطلحات موضوعية: anti-tnf discontinuation, certolizumab pegol, double-blind trial, evidence-based consensus, inflammatory-bowel-disease, long-term, maintenance therapy, metaanalysis comparative efficacy, necrosis factor therapy, network metaanalysis

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1093/ecco-jcc/jjz180Test
https://cris.maastrichtuniversity.nl/en/publications/ff96799e-7081-408e-b37b-cb7cf498810fTest
https://cris.maastrichtuniversity.nl/ws/files/77793040/Stassen_2020_ECCO_Guidelines_on_therapeutics_in.pdfTest

المؤلفون: Chaparro, Maria, Donday, Maria G., Barreiro-de Acosta, Manuel, Domenech, Eugeni, Esteve, Maria, Garcia-Sanchez, Valle, Nos, Pilar, Panes, Julian, Martinez, Concepcion, Gisbert, Javier P., EXIT Study Grp GETECCU

المساهمون: Gisbert, Javier P. Univ Autonoma Madrid, Gastroenterol Dept, Hosp Univ La Princesa, Inst Invest Sanitaria Princesa IIS IP,CIBEREHD, Diego de Leon 62, Madrid 28006, Spain, Chaparro, Maria Univ Autonoma Madrid, Gastroenterol Dept, Hosp Univ La Princesa, IIS IP,CIBEREHD, Madrid, Spain, Donday, Maria G. Univ Autonoma Madrid, Gastroenterol Dept, Hosp Univ La Princesa, IIS IP,CIBEREHD, Madrid, Spain, Barreiro-de Acosta, Manuel Hosp Clin Univ Santiago de Compostela, Gastroenterol Dept, Santiago De Compostela, A Coruna, Spain, Domenech, Eugeni Hosp Badalona Germans Trias & Pujol, CIBEREHD, Gastroenterol Dept, Badalona, Spain, Esteve, Maria Hosp Univ Mutua Terrasa, CIBEREHD, Gastroenterol Dept, Barcelona, Spain, Garcia-Sanchez, Valle Hosp Univ Reina Sofia, Gastroenterol Dept, Cordoba, Spain, Nos, Pilar Hosp Univ & Politecn La Fe, CIBEREHD, Gastroenterol Dept, Valencia, Spain, Panes, Julian IDIBAPS, Gastroenterol Dept, IBD Unit, Hosp Clin,CIBEREHD, Barcelona, Spain, Martinez, Concepcion Hosp Univ La Princesa, Serv Farm, Gastroenterol Dept, Madrid, Spain, Instituto de Salud Carlos III, FEDER funds

مصطلحات موضوعية: anti-tumour necrosis factor, inflammatory bowel disease, withdrawal, Spanish work productivity, Anti-tnf discontinuation, Evidence-based consensus, Crohns-disease, Ulcerative-colitis, Relapse, Questionnaire, Validation, Therapy, Management

العلاقة: http://hdl.handle.net/10668/19102Test; 486476900001

الإتاحة: https://doi.org/10.1177/1756284819874202Test
http://hdl.handle.net/10668/19102Test

المؤلفون: Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, Paul Collins, Alaa El-Hussuna, Pierre Ellul, Cornelia Frei-Lanter, Federica Furfaro, Christian Gingert, Paolo Gionchetti, Fernando Gomollon, Marien González-Lorenzo, Hannah Gordon, Tibor Hlavaty, Pascal Juillerat, Konstantinos Katsanos, Uri Kopylov, Eduards Krustins, Theodore Lytras, Christian Maaser, Fernando Magro, John Kenneth Marshall, Pär Myrelid, Gianluca Pellino, Isadora Rosa, Joao Sabino, Edoardo Savarino, Antonino Spinelli, Laurents Stassen, Mathieu Uzzan, Stephan Vavricka, Bram Verstockt, Janindra Warusavitarne, Oded Zmora, Gionata Fiorino

المساهمون: Torres, J., Bonovas, S., Doherty, G., Kucharzik, T., Gisbert, J. P., Raine, T., Adamina, M., Armuzzi, A., Bachmann, O., Bager, P., Biancone, L., Bokemeyer, B., Bossuyt, P., Burisch, J., Collins, P., El-Hussuna, A., Ellul, P., Frei-Lanter, C., Furfaro, F., Gingert, C., Gionchetti, P., Gomollon, F., Gonzalez-Lorenzo, M., Gordon, H., Hlavaty, T., Juillerat, P., Katsanos, K., Kopylov, U., Krustins, E., Lytras, T., Maaser, C., Magro, F., Kenneth Marshall, J., Myrelid, P., Pellino, G., Rosa, I., Sabino, J., Savarino, E., Spinelli, A., Stassen, L., Uzzan, M., Vavricka, S., Verstockt, B., Warusavitarne, J., Zmora, O., Fiorino, G., Torres J., Bonovas S., Doherty G., Kucharzik T., Gisbert J.P., Raine T., Adamina M., Armuzzi A., Bachmann O., Bager P., Biancone L., Bokemeyer B., Bossuyt P., Burisch J., Collins P., El-Hussuna A., Ellul P., Frei-Lanter C., Furfaro F., Gingert C., Gionchetti P., Gomollon F., Gonzalez-Lorenzo M., Gordon H., Hlavaty T., Juillerat P., Katsanos K., Kopylov U., Krustins E., Lytras T., Maaser C., Magro F., Kenneth Marshall J., Myrelid P., Pellino G., Rosa I., Sabino J., Savarino E., Spinelli A., Stassen L., Uzzan M., Vavricka S., Verstockt B., Warusavitarne J., Zmora O., Fiorino G., Surgery, MUMC+: MA Heelkunde (9), MUMC+: MA AIOS Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health

المصدر: Torres, J, Bonovas, S, Doherty, G, Kucharzik, T, Gisbert, J P, Raine, T, Adamina, M, Armuzzi, A, Bachmann, O, Bager, P, Biancone, L, Bokemeyer, B, Bossuyt, P, Burisch, J, Collins, P, El-Hussuna, A, Ellul, P, Frei-Lanter, C, Furfaro, F, Gingert, C, Gionchetti, P, Gomollon, F, González-Lorenzo, M, Gordon, H, Hlavaty, T, Juillerat, P, Katsanos, K, Kopylov, U, Krustins, E, Lytras, T, Maaser, C, Magro, F, Marshall, J K, Myrelid, P, Pellino, G, Rosa, I, Sabino, J, Savarino, E, Spinelli, A, Stassen, L, Uzzan, M, Vavricka, S, Verstockt, B, Warusavitarne, J, Zmora, O, Fiorino, G & European Crohn’s and Colitis Organisation (ECCO) 2020, ' ECCO Guidelines on Therapeutics in Crohn's Disease : medical treatment ', Journal of Crohn's & Colitis, vol. 14, no. 1, pp. 4-22 . https://doi.org/10.1093/ecco-jcc/jjz180Test
Torres, J, Bonovas, S, Doherty, G, Kucharzik, T, Gisbert, J P, Raine, T, Adamina, M, Armuzzi, A, Bachmann, O, Bager, P, Biancone, L, Bokemeyer, B, Bossuyt, P, Burisch, J, Collins, P, El-Hussuna, A, Ellul, P, Frei-Lanter, C, Furfaro, F, Gingert, C, Gionchetti, P, Gomollon, F, González-Lorenzo, M, Gordon, H, Hlavaty, T, Juillerat, P, Katsanos, K, Kopylov, U, Krustins, E, Lytras, T, Maaser, C, Magro, F, Marshall, J K, Myrelid, P, Pellino, G, Rosa, I, Sabino, J, Savarino, E, Spinelli, A, Stassen, L, Uzzan, M, Vavricka, S, Verstockt, B, Warusavitarne, J, Zmora, O, Fiorino, G & European Crohn’s and Colitis Organisation (ECCO) 2020, ' ECCO Guidelines on Therapeutics in Crohn's Disease : medical treatment ', Journal of Crohn's & colitis, vol. 14, no. 1, pp. 4-22 . https://doi.org/10.1093/ecco-jcc/jjz180Test
Journal of Crohn's & Colitis, 14(1), 4-22. Oxford University Press

مصطلحات موضوعية: long-term, MAINTENANCE THERAPY, Science & Technology, evidence-based consensus, Gastroenterology & Hepatology, inflammatory-bowel-disease, ANTI-TNF DISCONTINUATION, LONG-TERM, NETWORK METAANALYSIS, induction therapy, NECROSIS FACTOR THERAPY, Gastroenterology, General Medicine, DOUBLE-BLIND TRIAL, therapy of fistulising perianal disease, certolizumab pegol, CERTOLIZUMAB PEGOL, EVIDENCE-BASED CONSENSUS, METAANALYSIS COMPARATIVE EFFICACY, 610 Medicine & health, Life Sciences & Biomedicine, INFLAMMATORY-BOWEL-DISEASE

وصف الملف: STAMPA; application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b344239ef14659ca697fdeca76029485Test
https://doi.org/10.1093/ecco-jcc/jjz180Test

المؤلفون: CHIMENTI, MARIA SOLE, GRACEFFA, DARIO, PERRICONE, ROBERTO

المساهمون: Chimenti, M, Graceffa, D, Perricone, R

مصطلحات موضوعية: Anti-TNF discontinuation, Disease relapse, Disease remission, Psoriatic arthriti, Rheumatoid arthriti, Animal, Antirheumatic Agent, Arthritis, Psoriatic, Rheumatoid, Human, Practice Guidelines as Topic, Remission Induction, Secondary Prevention, Tumor Necrosis Factor-alpha, Withholding Treatment, Immunology, Immunology and Allergy

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21536151; info:eu-repo/semantics/altIdentifier/wos/WOS:000295347400011; volume:10; issue:10; firstpage:636; lastpage:640; numberofpages:5; journal:AUTOIMMUNITY REVIEWS; http://hdl.handle.net/2108/119641Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-80051670470

الإتاحة: https://doi.org/10.1016/j.autrev.2011.04.015Test
http://hdl.handle.net/2108/119641Test

المؤلفون: Maria Sole Chimenti, Roberto Perricone, Dario Graceffa

المصدر: Autoimmunity reviews. 10(10)

مصطلحات موضوعية: Disease relapse, medicine.medical_specialty, Immunology, Psoriatic, Disease, Arthritis, Rheumatoid, Anti-TNF discontinuation, Disease remission, Psoriatic arthritis, Rheumatoid, Internal medicine, medicine, Secondary Prevention, Immunology and Allergy, Animals, Humans, Rheumatoid arthritis, business.industry, Tumor Necrosis Factor-alpha, Arthritis, Standard treatment, Arthritis, Psoriatic, Remission Induction, medicine.disease, Surgery, Discontinuation, Settore MED/16 - Reumatologia, Regimen, Withholding Treatment, Antirheumatic Agents, Practice Guidelines as Topic, Tumor necrosis factor alpha, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aa3f1d1026a2ccb7c3164b11a12bafeTest
https://pubmed.ncbi.nlm.nih.gov/21536151Test

المؤلفون: Torres, J.

المصدر: Journal of Crohn's & Colitis vol.14 (2020) date: 2020-01-01 nr.1 p.4-22 [ISSN 1873-9946]

مصطلحات الفهرس: anti-tnf discontinuation, certolizumab pegol, double-blind trial, evidence-based consensus, inflammatory-bowel-disease, long-term, maintenance therapy, metaanalysis comparative efficacy, necrosis factor therapy, network metaanalysis, LONG-TERM, METAANALYSIS COMPARATIVE EFFICACY, CERTOLIZUMAB PEGOL, ANTI-TNF DISCONTINUATION, MAINTENANCE THERAPY, NETWORK METAANALYSIS, INFLAMMATORY-BOWEL-DISEASE, EVIDENCE-BASED CONSENSUS, DOUBLE-BLIND TRIAL, NECROSIS FACTOR THERAPY, Article

URL: https://cris.maastrichtuniversity.nl/en/publications/ff96799e-7081-408e-b37b-cb7cf498810fTest
https://cris.maastrichtuniversity.nl/ws/files/77793040/Stassen_2020_ECCO_Guidelines_on_therapeutics_in.pdfTest
https://cris.maastrichtuniversity.nl/ws/files/77793040/Stassen_2020_ECCO_Guidelines_on_therapeutics_in.pdfTest